Eli Lilly Analyst Ratings
Eli Lilly Price Target Maintained With a $885.00/Share by Cantor Fitzgerald
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
Eli Lilly Analyst Ratings
BofA Securities Initiates Eli Lilly and Co(LLY.US) With Buy Rating
J.P. Morgan Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,100
Citi Initiates Eli Lilly and Co(LLY.US) With Buy Rating, Announces Target Price $1,060
Eli Lilly & Co (LLY) Gets a Buy From Citi
Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating
Eli Lilly Price Target Maintained With a $885.00/Share by Cantor Fitzgerald
Eli Lilly Analyst Ratings
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Barclays Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,050
TD Cowen Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,050
Evercore Maintains Eli Lilly and Co(LLY.US) With Hold Rating
Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025
Analysts' Top Healthcare Picks: Alnylam Pharma (ALNY), Eli Lilly & Co (LLY)
A Quick Look at Today's Ratings for Eli Lilly and Co(LLY.US), With a Forecast Between $1,025 to $1,113
No Data
No Data